Septicemia due to Aeromonas hydrophila: clinical and immunologic aspects.
D000328:Adult; D000333:Aeromonas / Q000187:drug effects / Q000302:isolation & purification*; D000368:Aged; D000728:Androgens / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001770:Blood Bactericidal Activity; D002648:Child; D003428:Cross Infection / Q000097:blood / Q000209:etiology* / Q000276:immunology; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D009895:Opsonin Proteins; D010587:Phagocytosis; D018805:Sepsis / Q000097:blood / Q000209:etiology* / Q000276:immunology; D012874:Skin Diseases, Infectious / Q000209:etiology
D000728:Androgens; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D009895:Opsonin Proteins